University spinoffs have remarkably strengthened the linkage between universities and industry. The number of technology patents and spinoffs coming out of university research has a significant impact on regional economic and social development.
In this episode of o2h ChaiTime, Sunil Shah hosted a discussion around UK and USA university spinouts to help understand both the academic and entrepreneur considerations to maximize stakeholder value.
Peter Lane, works for The Sussex Innovation Centre engaging closely with the Knowledge Exchange office at the University of Sussex in supporting academics to spinout companies across a range of technologies.
Christine Martin, head of life science investments at Cambridge University, she is currently active with high profile spinouts Pharmenable, Spirea, Carrick Therapeutics, STORM Therapeutics, Z-factor, PhoreMost, Qkine and PolyProX.
Vinit Nijhawan, an excited visionary entrepreneur building companies that have been acquired by Boeing, Motorola and Qualcomm; he has served as the Managing Director for the Office of Technology Development at Boston University and is currently the Interim Executive Director of the Massachusetts Technology Transfer Center and Massachusetts Association of Technology Transfer Offices
Sunil Shah is a serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.